Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMost people notice semaglutide starting to work within the first one to two weeks — a quieter appetite, smaller portions, less interest in snacking between meals. Measurable weight loss, though, usually takes four to eight weeks to show clearly on the scales, and the full effect builds over months as your prescriber moves your dose upward. These are prescription-only medicines: a clinician assesses whether Wegovy is suitable for you before any treatment begins.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Semaglutide works by activating GLP-1 receptors in the brain and gut, slowing how quickly food leaves your stomach and signalling fullness earlier in a meal. That mechanism switches on from the first dose. What changes early on is not the number on the scales but the background noise of hunger: many people describe it as food simply becoming less insistent.
The 0.25mg starting dose exists because jumping straight to a therapeutic level produces more nausea, vomiting and digestive disruption than most people want to tolerate. Think of the first four weeks as your system adjusting, not as wasted time. Side effects (nausea, occasional loose stools, a bit of fatigue) tend to peak shortly after a dose change and then settle, usually within a week or so. The NHS semaglutide medicines page has a full list of what to watch for and when.
Visible scale movement before week four is possible but not reliable. If it hasn't happened yet, that is not a sign the medicine isn't working, it is a sign you are still in the dose-settling phase.
The clinical picture from the STEP 1 trial (1,961 adults with obesity, 68 weeks, semaglutide 2.4mg versus placebo) showed an average weight reduction of around 15%. But that headline number emerged gradually over the full course of treatment, not in the first month. Most participants reached the 2.4mg maintenance dose only at around week 16 to 20 after stepping through 0.5mg, 1.0mg and 1.7mg at roughly four-week intervals.
In practice, many people report noticeably smaller portions and less impulsive eating by weeks two to four, modest scale movement by weeks six to eight, and more consistent loss through months three to six as the dose climbs. The pace is not linear. Plateaus happen, often around dose transitions, and are a normal part of the pattern rather than a failure. If you are based locally and want to understand how Wegovy treatment works in Walsall, including how to get started near you, that page covers the specifics. More detail on the day-by-day timeline is worth reading if you are tracking closely.
One practical note: if you start treatment mid-week, around a bank holiday, or right before a fortnight away, the injection-day rhythm can slip in those first weeks. Semaglutide should be taken on the same day each week, your prescriber or the patient information leaflet can advise on what to do if a dose is delayed.
Semaglutide's half-life is approximately one week, which means the timing of your weekly injection matters far less than consistency. Taking it on the same day each week keeps your blood levels stable; the specific hour matters very little for the medicine's mechanism.
That said, some people find that injecting in the morning means any nausea peaks during the day when they are distracted, while others prefer evenings so they sleep through the worst of it. Neither is clinically superior, this is a personal preference decision, and choosing the best time of day for your injection covers the practical trade-offs clearly. What you should not do is switch injection day frequently in the hope of speeding results; that disrupts blood-level consistency without benefit.
If after several months on the maintenance dose you are seeing less than 5% weight loss, your prescriber will review whether continuing is the right call, this is in line with NICE's guidance on semaglutide (TA875). That review is a normal part of supervised treatment, not a failure on your part.
A few things are worth checking before concluding the medicine isn't effective. Diet composition changes significantly on semaglutide: protein adequacy and hydration both affect how well the reduced appetite translates into actual fat loss rather than muscle loss. Activity levels matter too. And dose, someone still on 0.5mg at month four is not yet on the dose the trial evidence supports. If you are wondering when Wegovy typically kicks in and what a realistic timeline looks like, that question is answered in detail, including what to expect at each dose stage. For a closer look at the early days specifically, how soon Wegovy kicks in after your first injection explains what is and is not normal in those opening weeks.
If you are considering whether Wegovy is the right option for you at all, or whether tirzepatide might suit your circumstances better, the weight-loss treatment overview lays out both options factually. Cost context, including what private treatment typically involves, is covered on the Wegovy pricing page. Our clinical team reviews every consultation personally, a prescriber reads your answers and history, not a system, and that is what a decision this significant deserves. Check your eligibility to start that conversation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.